Nathan Smith
Chief Executive / NeuroScientific Biopharmaceuticals
| Rank | Company | # | |
|---|---|---|---|
| 158th | - | NeuroScientific Biopharmaceuticals | $0 |
| Rank | Company | 1 Yr | 5 Yr |
|---|---|---|---|
| 1291st | Strickland Metals | -32.13% | 16.2% |
| 1292nd | Peak Processing | -32.15% | -43.82% |
| 1293rd | NeuroScientific Biopharmaceuticals | -32.17% | -29.35% |
| 1294th | Ausquest | -32.25% | 13.46% |
| 1295th | Summerset Group Holdings | -32.38% | -9.17% |
|
NEWS: Tagged in NeuroScientific hails 80% clinical response in Crohn’s stem cell program | 26 May 2026 |
|
NEWS: Tagged in NeuroScientific readies stem cell supply boost for bowel disease trials | 17 Mar 2026 |
|
NEWS: Tagged in NeuroScientific Biopharmaceuticals soars on stem cell tech results | 13 Jan 2026 |
|
NEWS: Tagged in NeuroScientific widens chronic bowel disease stem cell therapy program | 11 Nov 2025 |
|
NEWS: Tagged in NeuroScientific locks in deal to scale-up stem cell production | 31 Jul 2025 |
|
NEWS: Tagged in Board moves July 29, 2025 | 29 Jul 2025 |
|
NEW ROLE: Chief Executive, NeuroScientific Biopharmaceuticals | 29 Jul 2025 |
Access to our data for Nathan Smith is only available to paid subscribers with Data & Insights access.
Data & Insights is Western Australia's most accurate and comprehensive business listings and searchable database.
Nathan Smith is linked to 1 organisation which is included in 1 list - Public Companies - Industrial WA.
To see the data you will need to Subscribe.